Octopus Titan VCT plc : Amendment: Issue of Equ...
Octopus Titan VCT plc : Amendment: Issue of Equity, Closure of Offer and Total Voting Rights
Octopus Titan VCT plc
31 May 2017
Amendment: Issue of Equity, Closure of Offer and Total Voting Rights
Octopus Titan VCT plc (the "Company") announces an amendment to the RNS published at 08.46 on 10 April 2017, in which there was a reference to the offer for subscription (the "Offer") to raise up to £70 million, with an over allotment facility of £50 million, as set out in the prospectus dated 23 August 2016, being closed.
Whilst the Offer has been closed to further applications since 3pm on 6 March 2017, the Offer remains open in respect of certain applications received prior to 3pm on 6 March 2017 and in respect of which allotments will be made in due course.
For further information please contact:
Nicola Board Company Secretary 020 7776 8663
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Octopus Titan VCT plc via Globenewswire
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.